Impact of Exclusive Breast-Feeding in Guinea Bissau
Aspects of Exclusive Breast-Feeding in Guinea Bissau. Intervention Study to Clarify Recommendations for Breast-Feeding Policy in Developing Countries
2 other identifiers
interventional
1,500
1 country
1
Brief Summary
Exclusive breastfeeding is promoted by the World Health Organization (WHO) with the aim of improving infant health. The specific objective of the study was to examine the effect of exclusive breast-feeding on morbidity and mortality in a randomised prospective study. Children born by mothers recorded as living in the study area during pregnancy was randomised at birth. WHO recommendations to postpone introduction of water and weaning food were told to the mother by 2-weekly home visits. All study children were followed from birth till 1 year of age according to morbidity, hospitalisation and mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Mar 2000
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2000
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2002
CompletedFirst Submitted
Initial submission to the registry
August 18, 2005
CompletedFirst Posted
Study publicly available on registry
August 19, 2005
CompletedOctober 10, 2005
August 1, 2005
August 18, 2005
October 7, 2005
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Mortality
Morbidity
Secondary Outcomes (2)
Time to introduction of water
Time to introduction of weaning food
Interventions
Eligibility Criteria
You may qualify if:
- Children born in the study area in the period 1st March 2000 till 28th February 2001 by mothers recorded as living in the area during pregnancy.
You may not qualify if:
- Death before 7 days of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bandim Health Project, Apartado 861
Bissau, Guinea-Bissau
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Peter Aaby, Msc
Bandim Health Project, Statens Seruminstitut
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 18, 2005
First Posted
August 19, 2005
Study Start
March 1, 2000
Study Completion
February 1, 2002
Last Updated
October 10, 2005
Record last verified: 2005-08